Terms: = Uterine cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
18 results:
1. CESCProg: a compact prognostic model and nomogram for cervical cancer based on miRNA biomarkers.
Muthamilselvan S; Palaniappan A
PeerJ; 2023; 11():e15912. PubMed ID: 37786580
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
[TBL] [Abstract] [Full Text] [Related]
3. Infection status and survival impact of high-risk human papillomavirus in cervical adenocarcinomas: A systematic review and meta-analysis.
Chen H; Xiong W; Dong X; Liu Y; Tan X
Gynecol Oncol; 2022 Oct; 167(1):129-136. PubMed ID: 35973872
[TBL] [Abstract] [Full Text] [Related]
4. Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3.
Sun D; Cao R; Han L; Yu X; Wang H; Wang X; Chen X
Gynecol Obstet Invest; 2022; 87(3-4):200-210. PubMed ID: 35705019
[TBL] [Abstract] [Full Text] [Related]
5. Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma.
Ma H; Feng PH; Yu SN; Lu ZH; Yu Q; Chen J
BMC Cancer; 2022 May; 22(1):543. PubMed ID: 35562682
[TBL] [Abstract] [Full Text] [Related]
6. Early response to neoadjuvant chemotherapy helps decrease recurrence rate of cervical cancer: a systematic review and meta-analysis.
Hou Q; Shen J; Zhou S; Wei J; Wu M; Chen Q; Yan W; Zhang P; Yue Q; Wang S; Huang K
Ann Palliat Med; 2021 Jun; 10(6):6092-6103. PubMed ID: 34118837
[TBL] [Abstract] [Full Text] [Related]
7. Adjuvant therapy and prognosis in uterine carcinosarcoma.
Chiang CY; Huang HJ; Chang WY; Yang LY; Wu RC; Wang CC; Tung HJ; Chao A; Lai CH
J Formos Med Assoc; 2021 Nov; 120(11):1977-1987. PubMed ID: 33992491
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis.
An M; Duan H; Zhang Y
J Obstet Gynaecol Res; 2020 Sep; 46(9):1851-1863. PubMed ID: 32686169
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA EWSAT1 upregulates CPEB4 via miR-330-5p to promote cervical cancer development.
Zhou Q; Xie Y; Wang L; Xu T; Gao Y
Mol Cell Biochem; 2020 Aug; 471(1-2):177-188. PubMed ID: 32556917
[TBL] [Abstract] [Full Text] [Related]
10. [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome].
Lin L; Jiang QP; Lin D; Chen W; Jiang HP; Liu CH; Xiao YY; Zhu LT; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):471-476. PubMed ID: 29735450
[TBL] [Abstract] [Full Text] [Related]
11. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis.
Chu D; Wu J; Wang K; Zhao M; Wang C; Li L; Guo R
BMC Cancer; 2018 Apr; 18(1):438. PubMed ID: 29669520
[TBL] [Abstract] [Full Text] [Related]
12. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
[TBL] [Abstract] [Full Text] [Related]
13. National cancer Database Report of Lymphadenectomy Trends in Endometrial cancer.
Cripe J; Handorf E; Brown J; Jain A; Rubin S; Mantia-Smaldone G
Int J Gynecol Cancer; 2017 Sep; 27(7):1408-1415. PubMed ID: 28525495
[TBL] [Abstract] [Full Text] [Related]
14. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract] [Full Text] [Related]
16. uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.
Behtash N; Hashemi R; Karimi Zarchi M
Asian Pac J Cancer Prev; 2009; 10(1):163-6. PubMed ID: 19469647
[TBL] [Abstract] [Full Text] [Related]
17. Unexplained anaemia and failure to thrive as initial symptoms of infantile choriocarcinoma: a review.
Blohm ME; Göbel U
Eur J Pediatr; 2004 Jan; 163(1):1-6. PubMed ID: 14628141
[TBL] [Abstract] [Full Text] [Related]
18. [Trophoblastic disease in data from the Center for Trophoblastic Disease (diagnosis, therapy and results form 1955 to 1996). 1].
Zavadil M
Ceska Gynekol; 1997 Apr; 62(2):67-71. PubMed ID: 9296795
[TBL] [Abstract] [Full Text] [Related]
